Caribou Biosciences, Inc. (NASDAQ: CRBU) reported Q2 EPS of ($0.35), $0.04 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $2.67 million versus the consensus estimate of $2.09 million.

For earnings history and earnings-related data on Caribou Biosciences, Inc. (CRBU) click here.